Cargando…
Biomarkers in Routine Heart Failure Clinical Care
Heart failure is a clinical condition with complex pathophysiology that involves many different processes. Diagnosis is often difficult in patients presenting for the first time with breathlessness. Many biomarkers have been identified that are elevated in heart failure and their role in assessing p...
Autores principales: | Nadar, Sunil K, Shaikh, Mohammad Mujtaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396063/ https://www.ncbi.nlm.nih.gov/pubmed/30847246 http://dx.doi.org/10.15420/cfr.2018.27.2 |
Ejemplares similares
-
Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
por: Nadar, Sunil K, et al.
Publicado: (2019) -
Variability of biomarkers in patients with chronic heart failure and healthy controls
por: Meijers, Wouter C., et al.
Publicado: (2016) -
The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010) -
A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020) -
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)